equity financing

FDA Grants Priority Review to AstraZeneca’s Baxdrostat NDA for Hard-to-Control Hypertension

Cambridge, UK & Wilmington, Delaware, December 2025 — AstraZeneca has announced that the U.S. Food and Drug Administration has...

By cGxPwire Editor
December 3, 2025

Pharma

Formosa Licenses Ophthalmic Clobetasol Suspension to Rxilient for Asia Commercialization

Taipei, Taiwan, December 2025 — Formosa Pharmaceuticals has announced a licensing agreement with Rxilient Biotech to commercialize clobetasol propionate...

By cGxPwire Editor
December 3, 2025

.VC

Kazia Therapeutics Secures $50M Private Placement to Strengthen Pipeline Funding

Sydney, Australia, December 3, 2025 — Kazia Therapeutics has announced the pricing of a US $50 million private placement...

By cGxPwire Editor
December 3, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

FDA Grants Priority Review to AstraZeneca’s Baxdrostat NDA for Hard-to-Control Hypertension

Formosa Licenses Ophthalmic Clobetasol Suspension to Rxilient for Asia Commercialization

Kazia Therapeutics Secures $50M Private Placement to Strengthen Pipeline Funding